# Nabdah Phase 2 — Patient application audit closure double-check

## Closure decision

**Phase 2 is closed as a source-audit and evidence phase only.** It is **not** a release approval and it does not mark any documented defect as remediated. All confirmed source changes remain deferred to **Phase 8** under the approved sequence; device, production E2E, payment, legal-consent, and clinical-governance validation remain explicitly outside this closure.

## Double-check against approved Phase 2 scope

| Scope item | Double-check result | Evidence | Closure status |
|---|---|---|---|
| Authoritative source, app inventory, action inventory, and API route mapping | Baseline and full inventory completed; provisional route findings manually classified. | Patient inventory/route-match artifacts and decision matrix | PASS/FIX tracked |
| Build gate | TypeScript, Jest, Expo export, and Android prebuild passed in the isolated verification environment; native APK/device gate is separately blocked by environment. | `NABDAH_BUILD_ENVIRONMENT_GATE_20260818.md` | PASS with device blocker recorded |
| Core patient workflow reviews | Pharmacy/consultations/family/medication/nutrition/maternity/mental-health findings were previously captured; remaining profile, reports, nursing, diagnostics, wallet, loyalty, notifications, privacy, data, support, and AI surfaces were now reviewed. | Closure matrix rows 16–26 and linked artifacts | PASS/FIX/BLOCKED classified |
| Ownership and data truthfulness | Protected report, notification, emergency-contact, lab, and selected wallet/loyalty controls were verified where source supports them; all BOLA, PHI, payment, and medical-safety gaps are recorded as fail-closed remediation items. | Individual Phase 2 gap artifacts | FIX/BLOCKED, not silently accepted |
| UX, localization, state handling | Raw Arabic strings, forced/implicit direction issues, fabricated data, no-op controls, and error-state gaps are recorded rather than treated as production-ready. | Patient UI/UX baseline plus feature artifacts | FIX |
| Closure governance | No Patient source was silently merged or changed during the audit. Evidence and master TODO were committed to `manus/on-live-reconciliation`; no production deployment was requested or performed. | Git history and branch verification | PASS |

## Reviewed remaining workflow evidence

| Workflow | Determination | Artifact |
|---|---|---|
| Monthly report; medical report viewer and report AI | Contract/parameter/localization/PHI gaps documented. | `NABDAH_PHASE2_MONTHLY_REPORT_DATA_LOCALIZATION_GAP_20260819.md`; `NABDAH_PHASE2_MEDICAL_REPORT_VIEWER_AND_AI_CONTRACT_GAPS_20260819.md` |
| Home-care nursing; laboratory and radiology | Booking, slot, insurance, tracking, safety and ownership gaps documented. | `NABDAH_PHASE2_HOME_CARE_NURSING_WORKFLOW_CONTRACT_GAPS_20260819.md`; `NABDAH_PHASE2_DIAGNOSTICS_LAB_RADIOLOGY_WORKFLOW_GAPS_20260819.md` |
| Wallet; loyalty | Financial atomicity, idempotency, saved card, terms and redemption gaps documented. | `NABDAH_PHASE2_WALLET_TRANSFER_CARD_CONTRACT_GAPS_20260819.md`; `NABDAH_PHASE2_LOYALTY_REWARD_CONTRACT_GAPS_20260819.md` |
| Profile; emergency contacts; notifications; privacy; data | Owner-scoped controls separated from profile defaults, unenforced preferences, no-op rights controls and unsupported assurances. | `NABDAH_PHASE2_PROFILE_NOTIFICATION_SETTINGS_GAPS_20260819.md` |
| Symptom checker, triage, virtual doctor and drug interaction scanner | P0 clinical-safety, privacy, contract and emergency-boundary gaps documented. | `NABDAH_PHASE2_TRIAGE_DRUG_INTERACTION_SAFETY_GAPS_20260819.md` |
| Skin analysis and prescription OCR | P0 image/document-consent, fabricated output, untyped contract and clinical-verification gaps documented. | `NABDAH_PHASE2_SKIN_ANALYSIS_SAFETY_PRIVACY_GAPS_20260819.md`; `NABDAH_PHASE2_PRESCRIPTION_TRANSLATOR_CONTRACT_SAFETY_GAPS_20260819.md` |
| Support tickets and chat | Owned ticket list separated from invalid chat route, fabricated availability and attachment-context gaps. | `NABDAH_PHASE2_SUPPORT_CHAT_TICKET_CONTRACT_GAPS_20260819.md` |

## Mandatory handoff to later phases

Phase 3 begins automatically with the Provider application audit. Phase 5 and Phase 6 must independently revalidate Backend/Database and security conclusions, including the radiology ownership, wallet/loyalty transaction boundaries, privacy-consent enforcement, and AI endpoints. Phase 8 owns implementation of every confirmed remediation item. Phase 9–11 must supply build, device, and sandbox production evidence before any release decision.

> **Release rule:** The presence of a Phase 2 closure document means audit coverage is complete for this phase; it does not mean that the Patient application is deployable, clinically approved, payment-ready, or store-ready.
